MFS
TGTX icon

MSI Financial Services’s TG Therapeutics TGTX Stock Holding History

MSI Financial Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$19K Buy
+4,000
New +$23.5K ﹤0.01% 2433
2016
Q3 		– Sell
-2,000
Closed -$12K – 4021
2016
Q2 		$12K Buy
+2,000
New +$16.3K ﹤0.01% 2667

Other funds holding TGTX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

MSI Financial Services's TGTX Position: Q4 2016 in Review

MSI Financial Services opened a new position in TG Therapeutics (TGTX) in Q4 2016: 4,000 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #2433 among its holdings. This is a return to the name: MSI Financial Services previously reported a position in TGTX as recently as Q2 2016.

MSI Financial Services first reported a position in TGTX in Q2 2016 and has held it in 2 quarters since. 91 funds tracked by Wall St. Rank hold TGTX as of Q4 2016.

  • MSI Financial Services held 4,000 shares of TG Therapeutics worth $19K as of Q4 2016.
  • TG Therapeutics was a new MSI Financial Services position in Q4 2016.
  • TG Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2433 holding.
  • MSI Financial Services first reported a position in TG Therapeutics in Q2 2016 and has held it in 2 quarters since.
  • 91 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.